Andson Biotech Secures $2 Million NIH SBIR Phase II Award to Advance Automated DynaChip™ for Biotherapeutic Characterization

Atlanta, GA — September 28, 2026 —Andson Biotech, a pioneer in online sample preparation innovation, has been awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health (NIH). The funding will support development and commercialization of the company’s automated DynaChip™ platform, a next-generation system designed to expand […]

Andson Biotech to Present New Advances in Biotherapeutics Analysis at CASSS MS 2026

Atlanta, GA — September 2, 2026 — Andson Biotech is excited to announce its participation in the CASSS Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (CASSS MS 2026), taking place September 15-18, 2026, in Rockville, Maryland. During the meeting, Andson scientists will present new research demonstrating how automated online buffer […]

Andson Biotech to Present and Exhibit at the 46th BMSS Annual Meeting 2026 in Leeds

Atlanta, GA — Aug 17, 2026 — Andson Biotech is pleased to announce its participation in the 46th British Mass Spectrometry Society (BMSS) Annual Meeting, taking place September 8–10, 2026, in Leeds, United Kingdom. As one of the premier mass spectrometry conferences in Europe, BMSS 2026 will bring together scientists, technology innovators, and industry leaders […]